EUVIMEDEUVIMED entdecken
Crossref

Herbal Drugs Used For Neurodegenerative Diseases: Mechanisms, Evidence, And Future Directions

Prof Dr Mohammed Ghazi Sghaireen, Dr Amira Mira, Dr Lara M Sghaireen, Dr Rakhi Issrani

International Journal of Drug Delivery Technology · 14.04.2026 · 16 (9s)

DOI: 10.25258/ijddt.16.9s.92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.04.2026. Verfasst von Prof Dr Mohammed Ghazi Sghaireen und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementias share overlapping pathological mechanisms including oxidative stress, mitochondrial dysfunction, neuroinflammation, protein aggregation, and synaptic failure. In recent years, herbal drugs containing polyphenols, terpenoids, alkaloids, and saponins have attracted considerable attention for their multi-target neuroprotective actions, offering potential adjunctive value in managing these complex disorders.

Aim

To review major herbal drugs used in neurodegenerative diseases and summarise their bioactive constituents, mechanisms of neuroprotection, clinical evidence, limitations, and future research priorities. Methodology: This narrative review synthesised findings from recent preclinical and clinical studies, published systematic reviews, and pharmacological evidence concerning herbal agents with neuroprotective potential. Key herbs were analysed for their active constituents, molecular targets, therapeutic mechanisms, safety profiles, and evidence from clinical trials.

Results

Herbal drugs including Ginkgo biloba, Bacopa monnieri, Withania somnifera, curcumin (Curcuma longa), resveratrol-containing plants, and Panax ginseng demonstrated antioxidant, anti-inflammatory, antiamyloid, anti-apoptotic, neurotrophic, and cholinergic-modulating actions across multiple neurodegenerative pathways. While several exhibit promising preclinical results and modest clinical benefits, challenges remain, such as variable extract standardisation, poor bioavailability for some phytochemicals, limited large-scale randomised controlled trials, and potential herb–drug interactions.

Conclusion

Herbal drugs show significant mechanistic plausibility and preliminary clinical support as adjunctive therapies for neurodegenerative diseases. However, definitive evidence for disease-modifying effects is lacking. Future progress requires well-designed, standardised, multi-centre clinical trials alongside improved formulations and biomarker-integrated research approaches to validate long-term efficacy and safety.

Zitieren

APA

Sghaireen, P. D. M. G., Mira, D. A., Sghaireen, D. L. M., & Issrani, D. R. (2026). Herbal Drugs Used For Neurodegenerative Diseases: Mechanisms, Evidence, And Future Directions. International Journal of Drug Delivery Technology, 16(9s). https://doi.org/10.25258/ijddt.16.9s.92

Vancouver

Sghaireen PDMG, Mira DA, Sghaireen DLM, Issrani DR. Herbal Drugs Used For Neurodegenerative Diseases: Mechanisms, Evidence, And Future Directions. International Journal of Drug Delivery Technology. 2026;16(9s). doi:10.25258/ijddt.16.9s.92

BibTeX
@article{Sghaireen2026,
  author = {Sghaireen, Prof Dr Mohammed Ghazi and Mira, Dr Amira and Sghaireen, Dr Lara M and Issrani, Dr Rakhi},
  title = {Herbal Drugs Used For Neurodegenerative Diseases: Mechanisms, Evidence, And Future Directions},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {9s},
  doi = {10.25258/ijddt.16.9s.92}
}
Kostenlos starten →